Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Baptiste Rey

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Targeted Oncology|January 18, 2012
Colony stimulating factors (CSF) biosimilars. Progress?Florian Scotté, Vincent Launay-Vacher, Jean-Baptiste Rey
Targeted Oncology|September 13, 2014
Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacistsJean-Baptiste Rey, Vincent Launay-Vacher, Christophe Tournigand
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2006
Microbial growth tests in anti-neoplastic injectable solutionsIsabelle Paris, Angelo Paci, Jean-Baptiste Rey, et al.
PDA Journal of Pharmaceutical Science and Technology|November 9, 2006
Development of a ready-to-use antibiotic conservation solution for arterio-venous graftsChristophe Augé, Bertrand Gourdier, Véronique Reiter-Chenel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 7, 2003
Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unitPhilippe Bourget, Angelo Paci, Jean Baptiste Rey, et al.
Pharmacy World & Science : PWS|October 18, 2005
E.F.P.--European Fellowship for Pharmacists Promoting Clinical Pharmacy in EuropeAndré Rieutord, Tony Nunn, Vincent Launay-Vacher, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2008
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer CareVincent Launay-Vacher, Jean-Baptiste Rey, Corinne Isnard-Bagnis, et al.
Bulletin Du Cancer|December 8, 2011
[Management of analgesics in cancer patients with renal impairment]Jean-Baptiste Rey, Thao Tran, Didier Ammar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 27, 2014
Venous thromboembolism: What pharmacists know? What do they need?Jean-Baptiste Rey, Nicolas Jovenin, Pierre Kreit, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2004
Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patientsVincent Launay-Vacher, Hassane Izzedine, Jean-Baptiste Rey, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Targeted Oncology|January 18, 2012
Colony stimulating factors (CSF) biosimilars. Progress?Florian Scotté, Vincent Launay-Vacher, Jean-Baptiste Rey
Targeted Oncology|September 13, 2014
Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacistsJean-Baptiste Rey, Vincent Launay-Vacher, Christophe Tournigand
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2006
Microbial growth tests in anti-neoplastic injectable solutionsIsabelle Paris, Angelo Paci, Jean-Baptiste Rey, et al.
PDA Journal of Pharmaceutical Science and Technology|November 9, 2006
Development of a ready-to-use antibiotic conservation solution for arterio-venous graftsChristophe Augé, Bertrand Gourdier, Véronique Reiter-Chenel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 7, 2003
Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unitPhilippe Bourget, Angelo Paci, Jean Baptiste Rey, et al.
Pharmacy World & Science : PWS|October 18, 2005
E.F.P.--European Fellowship for Pharmacists Promoting Clinical Pharmacy in EuropeAndré Rieutord, Tony Nunn, Vincent Launay-Vacher, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2008
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer CareVincent Launay-Vacher, Jean-Baptiste Rey, Corinne Isnard-Bagnis, et al.
Bulletin Du Cancer|December 8, 2011
[Management of analgesics in cancer patients with renal impairment]Jean-Baptiste Rey, Thao Tran, Didier Ammar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 27, 2014
Venous thromboembolism: What pharmacists know? What do they need?Jean-Baptiste Rey, Nicolas Jovenin, Pierre Kreit, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2004
Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patientsVincent Launay-Vacher, Hassane Izzedine, Jean-Baptiste Rey, et al.
Pageof 2